France Drug Delivery Devices Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
Market Report I 2023-01-23 I 100 Pages I Mordor Intelligence
The French drug delivery devices market is anticipated to expand at a CAGR of 5.2% over the forecast period.
With the emergence of the COVID-19 pandemic, most pharmaceutical companies and governments have been/are working to provide adequate medical therapy to COVID-19 patients, and drug delivery devices are likely to play an essential role in this context. For example, large-scale vaccination programs are being implemented worldwide to immunize people against the SARS-COV-2 virus. However, many companies are still working on more efficient ways of delivering COVID-19 therapeutics to patients and are investing heavily in it, which is expected to impact the drug delivery market significantly. For instance, in January 2022, the BioMAP research team from the Infectiology and Public Health (ISP) joint research unit run by INRAE and the Universite de Tours developed a protein vaccine candidate for nasal administration to project against COVID-19 blocking all transmission of the virus. The Ministry of Higher Education, Research, and innovation supports the project and is accompanied by the National Agency for AIDS Research (ANRS). As a result, COVID-19 was predicted to impact the drug delivery market's growth substantially. Additionally, the market is anticipated to resume its rise during the projection period as more research and development is undertaken on COVID-19 vaccines and all restrictions are removed.
The rising prevalence of chronic diseases, technological advancements, and growth in the biologics market are some key factors driving the development of the France drug delivery devices market. Many disorders, including cardiovascular disease and diabetes, can benefit from targeted drug administration. The most important application of targeted medication delivery is the treatment of malignant tumors. As a result, the increasing prevalence of these disorders is likely to drive market expansion throughout the forecast period. For instance, the high burden of cancer can be explained by the latest statistics provided by the International Agency for Research on Cancer published GLOBOCAN 2020 report, which stated that in 2020, there were an estimated 467,965 new cancer cases diagnosed, where the male population accounted for 260,169 cases followed by female population with 207,796 cases. This shows a high burden of cancer among the target population. As a result, the population's increasing reliance on various drug types, including chemotherapy and intravenous therapy, is projected to fuel the market's expansion.
Thus, all the mentioned factors are expected to boost market growth over the forecast period. However, the risk of needlestick injury may restrain market growth over the forecast period.
France Drug Delivery Devices Market Trends
Diabetes Segment is Estimated to Witness Healthy Growth over the Forecast Period
The diabetes segment is driven by the increasing prevalence of diabetes in France and the product launches by the key market players. According to the International Diabetes Federation, in February 2022, the diabetic majority was 8.6%, with 3,942,900 adult diabetics in France in 2020. Additionally, according to the World Health Organization (WHO) May 2021, about a million are diagnosed with diabetes in France. The prevalence of diabetes is growing among all ages in France, which can be attributed to the growing obese population, unhealthy diets, and sedentary lifestyles. Thus, the rising prevalence of diabetes and obesity, growing awareness regarding diabetic care, healthcare expenditure, and technological advancements are a few factors that further drive the segment in France.
Furthermore, strategies adopted by the key market players, such as product launches, mergers, acquisitions, and partnerships, are likely to support market growth. For instance, in April 2021, BioCorp and Roche Diabetes Care France reported the launch of the Mallya smart insulin pen device in France. The device is designed to automatically gather insulin data (dose, date, and time) and upload it to Roche's Gluci-Chek application to ensure qualified information on which the patient can depend and the clinician may utilize to make informed clinical decisions. Additionally, in November 2021, Sanofi and Roche joined forces in France, teaming up to drive the adoption of a connected add-on for disposable insulin pens. The partners will jointly develop a scientific program for physicians and retail pharmacists around the Biocorp product. Thus, the segment is anticipated to witness significant growth over the forecast period due to the abovementioned factors.
Infectious Diseases is Expected to Hold Significant Share During the Forecast Period
Pathogenic microorganisms, such as bacteria, viruses, parasites, or fungi, cause infectious diseases. These diseases can spread directly or indirectly from one person to another. Common contagious diseases are Streptococcal Pharyngitis, urinary tract infections (caused by bacteria), HIV/AIDS, the common cold (caused by a virus), Athlete's foot (a common fungus), etc.
With the increasing burden of infectious diseases in France, the market is expected to project growth over the forecast period. According to the UNAIDS factsheet, in 2021, there were 190,000 HIV-positive persons in France. In 2021, the number of new HIV infections was 5,800. Regarding gender, men are more impacted than women, and it is most common among people aged 55 to 64. The region of Paris, known as Ile-de-France, has the highest rate of diagnoses. Thus, the country's growing prevalence of infectious diseases is expected to increase demand for drug-delivery devices, thereby boosting the market's growth over the forecast period.
Additionally, various initiatives the market players take are likely to support the market's growth over the forecast period. For instance, in November 2022, Aptar Pharma, a drug delivery company, completed the first phase of its announced USD 180 million expansion initiative to satisfy expanding customer capacity needs for injectable system solutions.
Thus, all factors above such as the growing prevalence of infectious diseases and strategic initiatives by market players, are expected to boost the market in the country over the forecast period.
France Drug Delivery Devices Market Competitor Analysis
The French drug delivery devices Market is moderately competitive and consists of several major players. Some companies currently dominating the market are Pfizer Inc., Novartis AG, F. Hoffmann-La Roche Ltd, Inc, Becton, Dickinson and Company, and 3M, among others.
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increased Prevalence of Chronic Diseases
4.2.2 Technological Advances
4.3 Market Restraints
4.3.1 Risk of Needlestick Injuries
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size By Value - USD million)
5.1 By Route of Administration
5.1.1 Injectable
5.1.2 Topical
5.1.3 Other Routes of Administration
5.2 By Application
5.2.1 Cancer
5.2.2 Cardiovascular
5.2.3 Diabetes
5.2.4 Infectious diseases
5.2.5 Other Applications
5.3 By End User
5.3.1 Hospitals
5.3.2 Ambulatory Centers
5.3.3 Other End Users
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 3M
6.1.2 Baxter International
6.1.3 Bayer AG
6.1.4 F. Hoffmann-La Roche AG
6.1.5 GlaxoSmithKline PLC
6.1.6 Johnson & Johnson
6.1.7 Merck & Co.
6.1.8 Novartis AG
6.1.9 Pfizer Inc
6.1.10 Sanofi
6.1.11 Becton, Dickinson and Company
6.1.12 Teva Pharmaceutical
6.1.13 Viatris Inc.
7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.